Generic Drugs Industrial and Market studies in Japan 2015-2019
"Generic
Drugs Market in Japan 2015-2019"
The Report covers current Market Trends, Worldwide Analysis, Global
Forecast, Review, Share, Size, Growth, Effect.
Description-
About
Generic Drugs
A generic drug is a duplicate of brand-name drugs and has the same
dosage form, active ingredient(s), potency, route of administration,
quality, and intended use as that of branded drugs. Generic drugs
enter the market once the patent protection of the original developer
expires. Generally, the cost of generic drugs is 50-70 percent lower
than that of their brand-name counterparts, while meeting the very
same standards of safety, quality, and efficacy as the innovator
drugs. Generic drugs help the manufacturer by eliminating the need to
develop and market a new drug.
As
the patent approaches expiration, manufacturers can apply to the FDA
for approval to manufacture and sell generic versions of the drug.
Generic drugs are equal to and within the bioequivalence range of
branded drugs.
TechNavio's analysts forecast the Generic Drugs market in Japan to
grow at a CAGR of 8.16 percent over the period 2014-2019.
Covered in this Report
The Generic Drugs market in Japan can be divided into three segments:
Generic Prescription Medicines, Super Generics, and Biosimilars. This
report covers the present scenario and the growth prospects of the
Generic Drugs market in Japan for the period 20152019. To calculate
the market size, the report considers the revenue generated from the
following segments:
Generic Prescription Medicines
- Super Generics
- Biosimilars
TechNavio's
report, the Generic Drugs market in Japan 2015-2019, has been
prepared based on an in-depth market analysis with inputs from
industry experts. The report covers the market landscape of the
Generic Drugs market in Japan and its growth prospects over the
coming years. The report also includes a discussion of the key
vendors operating in this market.
Key
Vendors
- Meiji Seika Pharma
- Nichi-Iko Pharmaceutical
- Nipro Pharma
- Sawai Pharmaceuticals
- Teva Pharmaceutical Industries
- Towa Pharmaceutical
Other
Prominent Vendors
- Actavis
- Daiichi Sankyo
- Daito Pharmaceutical
- Eisai
- Fuji Pharma
- GlaxoSmithKline
- Hikari Pharmaceutical
- Hospira
- Mylan
- Nihon Generic
- Nippon Chemipher
- Nippon Kayaku
- Nissin Pharmaceutical
- Ohara Pharmaceutical
- Pfizer
- Sandoz
- Taiyo Yakuhin
- Takeda Pharmaceutical
- Zensei Pharmaceutical Industries
Market
Driver
- Increase in Number of Patent Expiries
- For a full, detailed list, view our report.
Market
Challenge
- Intense Competition among Vendors
- For a full, detailed list, view our report
Market
Trend
- Increase in M&A
- For a full, detailed list, view our report
Key
Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
Comments
Post a Comment